Evaluation of N1539 Following Major Surgery

NCT02720692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

722

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Post-operative

Interventions

DRUG: N1539
DRUG: Intravenous Placebo

Sponsor

Baudax Bio